Y-Intercept (HK)’s Moderna MRNA Stock Holding History

Y-Intercept (HK)’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.79M	Buy	139,861 +123,351	+747%	+$6.38M	0.19%	95
2026 Q1	$839K	Sell	16,510 -444,343	-96%	-$20.7M	0.02%	1096
2025 Q4	$13.6M	Buy	+460,853	New	+$12.5M	0.3%	39
2025 Q3	–	Sell	-102,800	Closed	-$2.84M	–	1862
2025 Q2	$2.84M	Buy	+102,800	New	+$2.71M	0.07%	444
2025 Q1	–	Sell	-74,409	Closed	-$3.09M	–	1468
2024 Q4	$3.09M	Sell	74,409 -26,750	-26%	-$1.28M	0.21%	121
2024 Q3	$6.76M	Buy	101,159 +23,881	+31%	+$2.19M	0.41%	24
2024 Q2	$9.18M	Buy	+77,278	New	+$9.78M	0.5%	17
2023 Q4	–	Sell	-2,143	Closed	-$221K	–	1494
2023 Q3	$221K	Buy	+2,143	New	+$239K	0.02%	879
2023 Q1	–	Sell	-12,094	Closed	-$2.17M	–	1406
2022 Q4	$2.17M	Buy	+12,094	New	+$1.98M	0.32%	46
2022 Q3	–	Sell	-8,640	Closed	-$1.23M	–	1162
2022 Q2	$1.23M	Buy	+8,640	New	+$1.23M	0.16%	177
2022 Q1	–	Sell	-1,106	Closed	-$281K	–	865
2021 Q4	$281K	Buy	+1,106	New	+$323K	0.07%	416
2021 Q3	–	Sell	-38,178	Closed	-$8.97M	–	819
2021 Q2	$8.97M	Buy	38,178 +33,295	+682%	+$5.95M	2.28%	2
2021 Q1	$579K	Sell	4,883 -15,648	-76%	-$2.27M	0.16%	213
2020 Q4	$2.28M	Buy	+20,531	New	+$2.08M	0.96%	6

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Y-Intercept (HK)'s MRNA Position: Q2 2026 in Review

Y-Intercept (HK) increased its Moderna (MRNA) stake by 747% in Q2 2026, buying an estimated $6.38M and bringing the position to 139,861 shares worth $9.79M. The position accounts for 0.19% of the portfolio, ranked #95.

Y-Intercept (HK) first reported a position in MRNA in Q4 2020 and has held it in 14 quarters since. The position peaked at $13.6M in Q4 2025. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Y-Intercept (HK) held 139,861 shares of Moderna worth $9.79M as of Q2 2026.
Y-Intercept (HK) bought 123,351 Moderna shares in Q2 2026, an estimated $6.38M.
Moderna made up 0.19% of Y-Intercept (HK)'s portfolio in Q2 2026, its #95 holding.
Y-Intercept (HK) first reported a position in Moderna in Q4 2020 and has held it in 14 quarters since.
Y-Intercept (HK)'s Moderna position peaked at $13.6M in Q4 2025.
782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.